BIOCEPT INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BIOCEPT INC and buy or sell other stocks, ETFs, and their options commission-free!

About BIOCQ

Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company was founded on May 12, 1997 and is headquartered in San Diego, CA. 

CEO
Antonino Morales, CPA
CEOAntonino Morales, CPA
Employees
52
Employees52
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
52
Employees52

BIOCQ Key Statistics

Market cap
262.60
Market cap262.60
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
237.00
Average volume237.00
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.10
52 Week high$0.10
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current BIOCEPT INC(BIOCQ) stock price is $0.00, with a market capitalization of 262.6.

On 2026-05-22, BIOCEPT INC(BIOCQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for BIOCEPT INC(BIOCQ) stock has reached 0, versus its average volume of 237.

Over the past 52 weeks, BIOCEPT INC(BIOCQ) stock has traded between a high of $0.10 and a low of $0.00.

Over the past 52 weeks, BIOCEPT INC(BIOCQ) stock has traded between a high of $0.10 and a low of $0.00.

People also own

Based on the portfolios of people who own BIOCQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.